By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ocata Therapeutics (Formerly Known As Advanced Cell Technology) 

33 Locke Drive

Marlborough  Massachusetts   01752  U.S.A.
Phone: 580-756-1212 Fax: 580-229-2333


SEARCH JOBS








Company News
Ocata Therapeutics To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/18/2015 11:52:25 AM
Dr Robert Lanza, Chief Scientific Officer Of Ocata Therapeutics To Be A Featured Speaker At The Common Good Forum 5/11/2015 11:59:47 AM
Ocata Therapeutics Announces Positive Results In Treating Macular Degeneration Using Fully Differentiated Stem Cell-Derived Retinal Pigment Epithelium (RPE) Cells In Asian Patients 4/30/2015 10:51:43 AM
Ocata Therapeutics To Host Conference Call And Webcast To Provide Corporate Update For The Fourth Quarter And Full Year Of 2014 3/11/2015 10:54:49 AM
Advanced Cell Technology Changes Name To Ocata Therapeutics 11/14/2014 10:51:48 AM
Advanced Cell Technology To Host Conference Call And Webcast To Provide A Corporate Update For The Third Quarter Of 2014 11/7/2014 9:40:50 AM
Advanced Cell Technology Appoints Leroux Jooste As SVP Of Business Development & Chief Commercial Officer 10/20/2014 9:44:38 AM
Advanced Cell Technology Reports The Publication Of Research On The Scalable Generation Of Universal Platelets From Human Induced Pluripotent Stem Cells (iPSC) 10/17/2014 7:43:28 AM
Advanced Cell Technology Announces Positive Results from Two Clinical Trials Published In Lancet Using Differentiated Stem Cell-Derived Retinal Pigment Epithelium (RPE) Cells For The Treatment Of Macular Degeneration 10/15/2014 11:05:51 AM
Advanced Cell Technology Announces Final Patient Treated In Stargardt’s Macular Degeneration Phase 1 Trial In The United Kingdom 9/25/2014 8:42:31 AM
12345678910...
//-->